BNP Paribas Asset Management Portfolio holdings
AUM
$41B
This Quarter Return
+4.45%
1 Year Return
+19.31%
3 Year Return
+95.01%
5 Year Return
+143.6%
10 Year Return
+355.3%
AUM
$11.9B
AUM Growth
+$11.9B
(+0.62%)
Cap. Flow
-$379M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
14.91%
Holding
992
New
62
Increased
372
Reduced
395
Closed
39
Top Buys
| 1 |
VEON
VEON
|
$44.6M |
| 2 |
Leggett & Platt
LEG
|
$42M |
| 3 |
Lam Research
LRCX
|
$37.3M |
| 4 |
Premier
PINC
|
$36.5M |
| 5 |
Bunge Global
BG
|
$35.1M |
Top Sells
| 1 |
HES
Hess
HES
|
$88.3M |
| 2 |
CELG
Celgene Corp
CELG
|
$57.6M |
| 3 |
RTN
Raytheon Company
RTN
|
$47M |
| 4 |
Apple
AAPL
|
$47M |
| 5 |
Meta Platforms (Facebook)
META
|
$33M |
Sector Composition
| 1 | Technology | 15.54% |
| 2 | Healthcare | 13.61% |
| 3 | Financials | 13.57% |
| 4 | Consumer Discretionary | 13.17% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Las Vegas Sands
LVS
$38B
| $44.6M | 0.37% |
584,050
-11,875
| -2% | -$907K |
|
52
ConocoPhillips
COP
$118B
| $43.8M | 0.37% |
629,649
-109,579
| -15% | -$7.63M |
|
|
53
Leggett & Platt
LEG
$1.28B
| $43.6M | 0.37% |
977,026
+941,050
| +2,616% | +$42M |
|
54
3M
MMM
$81B
| $43.6M | 0.36% |
221,394
+26,600
| +14% | +$5.23M |
|
55
Sensata Technologies
ST
$4.63B
| $43.3M | 0.36% |
910,155
+1,372
| +0.2% | +$65.3K |
|
56
Zimmer Biomet
ZBH
$20.8B
| $43.2M | 0.36% |
387,586
+37,252
| +11% | +$4.15M |
|
57
Estee Lauder
EL
$33.1B
| $43.1M | 0.36% |
302,074
-3,558
| -1% | -$508K |
|
|
XYZ
58
Block, Inc.
XYZ
$46.2B
| $43M | 0.36% |
698,406
-241,177
| -26% | -$14.9M |
|
59
Chevron
CVX
$318B
| $43M | 0.36% |
340,225
+20,226
| +6% | +$2.56M |
|
60
Union Pacific
UNP
$132B
| $42.4M | 0.35% |
298,991
+16,305
| +6% | +$2.31M |
|
61
Abbott
ABT
$230B
| $41.2M | 0.35% |
676,294
+42,528
| +7% | +$2.59M |
|
62
Henry Schein
HSIC
$8.14B
| $41.2M | 0.35% |
567,105
+110,624
| +24% | +$8.04M |
|
63
McDonald's
MCD
$226B
| $40.8M | 0.34% |
260,155
-16,169
| -6% | -$2.53M |
|
64
Boston Scientific
BSX
$159B
| $40.6M | 0.34% |
1,242,220
-457,766
| -27% | -$15M |
|
65
Johnson & Johnson
JNJ
$429B
| $40M | 0.33% |
329,530
+72,229
| +28% | +$8.76M |
|
66
Jazz Pharmaceuticals
JAZZ
$7.99B
| $40M | 0.33% |
232,012
-41,769
| -15% | -$7.2M |
|
67
Intercontinental Exchange
ICE
$100B
| $39.8M | 0.33% |
541,389
-11,564
| -2% | -$851K |
|
68
Brunswick
BC
$4.15B
| $39.8M | 0.33% |
617,431
-217,174
| -26% | -$14M |
|
69
Starbucks
SBUX
$99.2B
| $39.6M | 0.33% |
809,742
+38,984
| +5% | +$1.9M |
|
70
DexCom
DXCM
$30.9B
| $39.4M | 0.33% |
414,686
+12,280
| +3% | +$1.17M |
|
71
Edwards Lifesciences
EW
$47.7B
| $39.3M | 0.33% |
270,161
-103,285
| -28% | -$15M |
|
72
CME Group
CME
$97.1B
| $39M | 0.33% |
237,803
+1,129
| +0.5% | +$185K |
|
73
FedEx
FDX
$53.2B
| $38.7M | 0.32% |
170,568
+23,740
| +16% | +$5.39M |
|
74
Occidental Petroleum
OXY
$45.6B
| $38.6M | 0.32% |
461,374
-28,289
| -6% | -$2.37M |
|
75
Pfizer
PFE
$141B
| $38.3M | 0.32% |
1,056,818
+85,928
| +9% | +$3.12M |
|